Improving removal of protein-bound retention solutes

Contributions to Nephrology

Volumn 149, Issue , 2005, Pages 175-184

  Bammens, Bert ^a   Evenepoel, Pieter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ADSORPTION; ARTIFICIAL MEMBRANE; DIFFUSION; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; PROTEIN BINDING; RENAL REPLACEMENT THERAPY; REVIEW; SYNDROME; THERMODYNAMICS; UREMIA;

ADSORPTION; CONVECTION; DIFFUSION; HUMANS; MEMBRANES, ARTIFICIAL; PROTEIN BINDING; RENAL DIALYSIS; SERUM ALBUMIN; SYNDROME; UREMIA;

EID: 20544478462     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000085487     Document Type: Review

References (36)

1. Merriam-Webster Online. Version current 1 January 2005. Internet: http://www.webster.com/cgi-bin/dictionary (accessed 13 January 2005).
2. Bergström J: Uremic toxicity; in Kopple JD, Massry SG (eds): Nutritional Management of Renal Disease. Baltimore, Williams & Wilkins, 1997, pp 97-190.
3. Vanholder R, De Smet R, Glorieux R, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W for the European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-1943.
4. Eknoyan G, Beck G, Cheung A, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R for the Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
5. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
6. Levin N, Greenwood R: Reflections on the HEMO study: The American viewpoint. Nephrol Dial Transplant 2003;18:1059-1060.
7. Locatelli F: Dose of dialysis, convection and haemodialysis patients outcome - What the HEMO study doen't tell us: The European viewpoint. Nephrol Dial Transplant 2003;18:1061-1065.
8. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R: Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 2000;15:50-57.
9. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003;64:2238-2243.
10. Suliman ME, Stenvinkel P, Qureshi AR, Barany P, Heimburger O, Anderstam B, Alvestrand A, Lindholm B: Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am J Kidney Dis 2004;44:455-465.
11. Niwa T, Asada H, Tsutsui S, Miyazaki T: Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol 1995;15:463-467.
12. Kushner D, Beckman B, Nguyen L, Chen S, Della Santina C, Husserl F, Rice J, Fisher JW: Polyamines in the anemia of end-stage renal disease. Kidney Int 1991;39:725-732.
13. Bagdade JD, Subbaiah PV, Bartos D, Bartos F, Campbell RA: Polyamines: An unrecognised cardiovascular risk factor in chronic dialysis. Lancet 1979;1:412-413.
14. Ottonello L, Gnerre P, Bertolotto M, Mancini M, Dapino P, Russo R, Garibotto G, Barreca T, Dallegri F: Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 2004;15:2366-2372.
15. Pecoits-Filho R, Nordfors L, Heimburger O, Lindholm B, Anderstam B, Marchlewska A, Stenvinkel P: Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J Clin Invest 2002;32:811-817.
16. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S: Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol. Kidney Int 1995;47:510-517.
17. Wratten ML, Tetta C, De Smet R, Neri R, Sereni L, Camussi G, Vanholder R: Uremic ultrafiltrate inhibits platelet-activating factor synthesis. Blood Purif 1999;17:134-141.
18. Dou L, Cerini C, Brunet P, Guilianelli C, Moal V, Grau G, De Smet R, Vanholder R, Sampol J, Berland Y: P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002;62:1999-2009.
19. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004;65:442-451.
20. Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, De Smet R, Vanholder R, Dignat-George F, Sampol J, Berland Y, Brunet P: P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004;92:140-150.
21. De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem 2003;49:470-478.
22. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T: Uremic toxins of organic anions upregulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int 2003;63:1671-1680.
23. Niwa T: Organic acids and the uremic syndrome: Protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 1996;16:167-182.
24. Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 2003;112:256-264.
25. Rashid G, Benchetrit S, Fishman D, Bernheim J: Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int 2004;66:1099-1106.
26. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999;14:1541-1549.
27. Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A: The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 2003;64:748-755.
28. Meyer TW, Leeper EC, Bartlett DW, Depner TA, Lit YZ, Robertson CR, Hostetter TH: Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 2004;15:1927-1935.
29. van Tellingen A, Grooteman MP, Bartels PC, van Limbeek J, van Guldener C, ter Wee PM, Nubé MJ: Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 2001;59:342-347.
30. De Vriese AS, Langlois M, Bernard D, Geerolf I, Stevens L, Boelaert JR, Schurgers M, Matthys E: Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients. Nephrol Dial Transplant 2003;18:2596-2600.
31. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R: Behavior of non-protein-bound and protein-bound solutes during daily hemodialysis. Am J Kidney Dis 2002;40:339-347.
32. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis 2004;44:278-285.
33. Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G: Hemodialyzer: From macro-design to membrane nanostructure: The case of the FX-class of hemodialyzers. Kidney Int 2002;61(suppl 80):S126-S142.
34. Clark WR, Macias WL, Molitoris BA, Wang NHL: Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995;48:481-488.
35. Evenepoel P, Maes B, Wilmer A, Nevens F, Fevery J, Kuypers D, Bammens B, Vanrenterghem Y: Detoxifying capacity and kinetics of the Molecular Adsorbent Recycling System Contribution of the different inbuilt filters. Blood Purif 2003;21:244-252.
36. Mitzner S, Stange J, Dillmonn A, Winkler RE, Michelson A, Knippel M, Schmidt R: Removal of protein-bound uremic toxins by albumin dialysis: In vivo results (abstract). Nephrol Dial Transplant 1999;14:A201.